The 2021 Conference on Retroviruses and Opportunistic Infections (CROI) will feature the best and newest research into HIV and related infections as well as SARS-CoV-2. In consideration of the evolving COVID-19 pandemic, CROI 2021 will include a virtual component that features 4.5 hours of live (real-time) interactive and engaging sessions in a variety of formats. New on-demand sessions will also be made available each day. Below is a preliminary outline of the content for CROI 2021. The agenda is under development and will be updated as additional information becomes available.
Program Committee Workshop for New Investigators and Trainees
Four hours of live presentations with question and answer period.
This workshop will describe the current state of the art of selected areas of HIV basic, epidemiologic, and clinical research being presented at CROI 2021. The workshop is directed toward new trainees (eg, undergraduate students, graduate students, postdoctoral fellows, and physician fellows) and new investigators (both international and domestic).
Live named-lecture and named-panel presentations (2 hours total)
- Bernard Fields Lecture
- N’Galy-Mann Lecture
- Martin Delaney Presentation
Concurrent Technical Workshops
Live presentations with question and answer period (1.5 hours)
- Frontiers in Laboratory Sciences
- Clinical Trial Design and Analysis
- Case-Based COVID-19 Clinical Workshop
The primary conference days feature 4 hours of live presentations as well as new on-demand content each day.
Live Content (4 hours each day)
- Welcome: A roadmap to the day’s content
- Plenary Session (1 hour): State-of-the-art presentations by 2 plenary speakers each day
- Concurrent Oral Abstract Sessions (2 hours): New abstract-driven research on HIV infection and related conditions as well as research on SARS-CoV-2
- Concurrent Interactive Sessions (1 hour): State-of-the-art presentations offered in a mixture of highly interactive formats (eg, dialogues with experts, point-counterpoint debates, panels, and facilitated discussions) with audience questions and answers
New Investigator Networking: New investigators and trainees will have the opportunity to sign up for small networking sessions with leaders in HIV research, treatment, and prevention.
Each day will feature newly released content. These on-demand sessions, as well as recordings of the live sessions, will be available to attendees through the remainder of the conference.
- Symposia: State-of-the-art presentations in basic science, treatment, and prevention of HIV, related infections, and COVID-19
- On-Demand Abstract Sessions: Science that is accepted but is not presented in the live oral sessions will be presented in an innovative format. Additional information will be released as it becomes available